Immune-evading tumours are generally characterised by high TGF-β expression, myeloid inflammation and tumour neovascularisation as microenvironmental features (Fukumura et al., 2018; Metelli et al., 2018; Hegde and Chen, 2020). This evidence concerns the gene TGFB1 and neoplasm.